Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages E182-E186

  Brower, Meredith A ^a   Jones, Michelle R ^b   Rotter, Jerome I ^c   Krauss, Ronald M ^d   Legro, Richard S ^e   Azziz, Ricardo ^f   Goodarzi, Mark O ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN RECEPTOR; INSULIN RECEPTOR; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DENND1A PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INSR PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; THADA PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BLOOD SAMPLING; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DENND1A GENE; EUROPEAN; FEMALE; FSHR GENE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSR GENE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; THADA GENE; ADULT; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

ADULT; ALLELES; ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; NEOPLASM PROTEINS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, INSULIN; RECEPTORS, FSH;

EID: 84920619412     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2689     Document Type: Article

References (24)

1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219-231.
2. Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43:55-59.
3. Goodarzi MO, Jones MR, Li X, et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet. 2012;49:90-95.
4. Welt CK,Styrkarsdottir U,Ehrmann DA,et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry J Clin Endocrinol Metab. 2012 97 E1342-E1347.
5. Shi Y,ZhaoH, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012; 44:1020-1025.
6. Louwers YV, Stolk L, Uitterlinden AG, Laven JS. Cross-ethnic metaanalysis of genetic variants for polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98:E2006-E2012.
7. Guo M, Chen ZJ, Eijkemans MJ, Gover de AJ, Fauser BC, Macklon NS. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod. 2012;27:1481-1488.
8. L egro RS, Myers ER, Barnhart HX, et al. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril. 2006;86:914-933.
9. Simon JA, Lin F, Hulley SB, et al. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol. 2006;97:843-850.
10. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril. 2009;91:456-488.
11. Jones MR, Chua AK, Mengesha EA, et al. Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids. 2012;77:317-322.
12. Voight BF, Kang HM, Ding J, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 2012;8:e1002793.
13. Mit tlbock M, Schemper M. Explained variation for logistic regression. Stat Med. 1996;15:1987-1997.
14. Eriksen MB, Nielsen MF, Brusgaard K, et al. Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS). PLoS One. 2013;8:e77186.
15. Lerchbaum E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Susceptibility loci for p olycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women. Horm Metab Res. 2011;43:743-747.
16. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Preva lence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067-3073.
17. McAllister JM, Modi B, Miller BA, et al. Overexpres sion of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. Proc Natl Acad Sci USA. 2014;111:E1519-E1527.
18. Wang P, Zhao H, Li T, et al. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome. Endocrinology. 2014;155: 1445-1452.
19. Mutharasan P, Galdones E, Penalver Bernabe B, et al. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab. 2013;98:E185-E190.
20. Sun L, Peng Y, Sharrow AC, et al. FSH directly regulates bone mass. Cell. 2006;125:247-260.
21. Lazaros L, Hatzi E, X ita N, et al. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI. J Reprod Med. 2013;58:395-401.
22. Goodarzi MO, Louwers YV, Taylor KD, et al . Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. Fertil Steril. 2011;95:1736-1741.
23. Moller DE, Yokota A, White MF, Pazianos AG, Flier JS.Anaturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem. 1990;265:14979-14985.
24. Azzi z R, Dumesic DA, Goodarzi MO. Polycystic ovary syndrome: an ancient disorder? Fertil Steril. 2011;95:1544-1548.